Limitations, agreements, and source contact

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401 · Source last updated 2018-01-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

true

point Of Contact

email

clinicaltrials@iderapharma.com

organization

Idera Pharmaceuticals, Inc.

phone

617-679-5500

title

Idera Medical Monitor

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice